Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6175418 | European Urology | 2014 | 13 Pages |
Abstract
We evaluated the ability of published biomarkers to predict the survival of patients with clear cell kidney cancer in an independent patient cohort. Only one molecular test adds prognostic information to routine clinical assessments. This marker showed good and poor prognosis results within most individual cancers. Future biomarkers need to consider variation within tumours to improve accuracy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sakshi Gulati, Pierre Martinez, Tejal Joshi, Nicolai Juul Birkbak, Claudio R. Santos, Andrew J. Rowan, Lisa Pickering, Martin Gore, James Larkin, Zoltan Szallasi, Paul A. Bates, Charles Swanton, Marco Gerlinger,